HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

c-Fos oncogene regulator Elk-1 interacts with BRCA1 splice variants BRCA1a/1b and enhances BRCA1a/1b-mediated growth suppression in breast cancer cells.

Abstract
Elk-1, a c-Fos protooncogene regulator, which belongs to the ETS-domain family of transcriptional factors, plays an important role in the induction of immediate early gene expression in response to a variety of extracellular signals. In this study, we demonstrate for the first time the in vitro and in vivo interaction of Elk-1 with BRCA1 splice variants BRCA1a and BRCA1b using GST-pull down assays, co-imunoprecipitations/Western blot analysis of cell extracts from breast cancer cells and mammalian two-hybrid assays. We have localized the BRCA1 interaction domain of Elk-1 protein to the conserved ETS domain, a motif involved in DNA binding and protein-protein interactions. We also observed binding of BRCA1 proteins to other ETS-domain transcription factors SAP1, ETS-1, ERG-2 and Fli-1 but not to Elk-1 splice variant DeltaElk-1 and c-Fos protooncogene. Both BRCA1a and BRCA1b splice variants function as growth suppressors of human breast cancer cells. Interestingly, our studies reveal that although both Elk-1 and SAP-1 are highly homologous members of a subfamily of ETS domain proteins called ternary complex factors, it is only Elk-1 but not SAP-1 that can augment the growth suppressive function of BRCA1a/1b proteins in breast cancer cells. Thus Elk-1 could be a potential downstream target of BRCA1 in its growth control pathway. Furthermore, we have observed inhibition of c-Fos promoter activity in BRCA1a transfected stable breast cancer cells and over expression of BRCA1a/1b attenuates MEK-induced SRE activation in vivo. These results demonstrate for the first time a link between the growth suppressive function of BRCA1a/1b proteins and signal transduction pathway involving Elk-1 protein. All these results taken together suggest that one of the mechanisms by which BRCA1a/1b proteins function as growth/tumor suppressors is through inhibition of the expression of Elk-1 target genes like c-Fos.
AuthorsY Chai, G Chipitsyna, J Cui, B Liao, S Liu, K Aysola, M Yezdani, E S Reddy, V N Rao
JournalOncogene (Oncogene) Vol. 20 Issue 11 Pg. 1357-67 (Mar 15 2001) ISSN: 0950-9232 [Print] England
PMID11313879 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • BRCA1 Protein
  • DNA-Binding Proteins
  • ELK1 protein, human
  • Nuclear Proteins
  • Proto-Oncogene Proteins
  • Serum Response Factor
  • Transcription Factors
  • ets-Domain Protein Elk-1
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases
Topics
  • Alternative Splicing
  • Animals
  • BRCA1 Protein (genetics, metabolism)
  • Breast Neoplasms (genetics, metabolism)
  • DNA-Binding Proteins
  • Female
  • Genes, Tumor Suppressor
  • Genes, fos (genetics)
  • Humans
  • Mammary Neoplasms, Animal (metabolism, pathology)
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases (metabolism)
  • Nuclear Proteins
  • Protein Binding
  • Proto-Oncogene Proteins (metabolism)
  • Response Elements
  • Serum Response Factor
  • Transcription Factors (metabolism)
  • ets-Domain Protein Elk-1

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: